← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2007-03-28

Drug application

FDA Application #

ANDA078250

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN

Generic name

NAPROXEN

Active ingredients

NAPROXEN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2007-03-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown